{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:17:52Z","timestamp":1791227872094,"version":"4.1.0"},"reference-count":110,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,1,1]]},"DOI":"10.1093\/eurheartj\/ehi020","type":"journal-article","created":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T01:13:49Z","timestamp":1101863629000},"page":"11-17","source":"Crossref","is-referenced-by-count":361,"title":["The severe cardiorenal syndrome: \u2018Guyton revisited\u2019"],"prefix":"10.1093","volume":"26","author":[{"given":"Lennart G.","family":"Bongartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten Jan","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter A.","family":"Doevendans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap A.","family":"Joles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branko","family":"Braam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2004,11,30]]},"reference":[{"key":"key\n\t\t\t\t20171012013638_EHI020C1","unstructured":"National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. USRDS 1997 Annual Data Report. Bethesda, MD, USA: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1997. http:\/\/www.usrds.org\/adr_1997.htm (11 November 2003)."},{"key":"key\n\t\t\t\t20171012013638_EHI020C2","unstructured":"Raine AE, Margreiter R, Brunner FP et al. Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant1992;7(Suppl. 2):7\u201335."},{"key":"key\n\t\t\t\t20171012013638_EHI020C3","doi-asserted-by":"crossref","unstructured":"Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol1998;9(Suppl. 12):S16\u2013S23.","DOI":"10.1053\/ajkd.1998.v32.pm9820470"},{"key":"key\n\t\t\t\t20171012013638_EHI020C4","doi-asserted-by":"crossref","unstructured":"Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med1998;339:799\u2013805.","DOI":"10.1056\/NEJM199809173391203"},{"key":"key\n\t\t\t\t20171012013638_EHI020C5","doi-asserted-by":"crossref","unstructured":"Zoccali C. Cardiorenal risk as a new frontier of nephrology: research needs and areas for intervention. Nephrol Dial Transplant2002;17(Suppl. 11):50\u201354.","DOI":"10.1093\/ndt\/17.suppl_11.50"},{"key":"key\n\t\t\t\t20171012013638_EHI020C6","doi-asserted-by":"crossref","unstructured":"Muntner P, He J, Hamm L et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol2002;13:745\u2013753.","DOI":"10.1681\/ASN.V133745"},{"key":"key\n\t\t\t\t20171012013638_EHI020C7","doi-asserted-by":"crossref","unstructured":"Henry RM, Kostense PJ, Bos G et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int2002;62:1402\u20131407.","DOI":"10.1111\/j.1523-1755.2002.kid571.x"},{"key":"key\n\t\t\t\t20171012013638_EHI020C8","doi-asserted-by":"crossref","unstructured":"Beddhu S, Allen-Brady K, Cheung AK et al. Impact of renal failure on the risk of myocardial infarction and death. Kidney Int2002;62:1776\u20131783.","DOI":"10.1046\/j.1523-1755.2002.00629.x"},{"key":"key\n\t\t\t\t20171012013638_EHI020C9","doi-asserted-by":"crossref","unstructured":"Fried LF, Shlipak MG, Crump C et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol2003;41:1364\u20131372.","DOI":"10.1016\/S0735-1097(03)00163-3"},{"key":"key\n\t\t\t\t20171012013638_EHI020C10","doi-asserted-by":"crossref","unstructured":"Manjunath G, Tighiouart H, Ibrahim H et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol2003;41:47\u201355.","DOI":"10.1016\/S0735-1097(02)02663-3"},{"key":"key\n\t\t\t\t20171012013638_EHI020C11","doi-asserted-by":"crossref","unstructured":"Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation2003;108:2154\u20132169.","DOI":"10.1161\/01.CIR.0000095676.90936.80"},{"key":"key\n\t\t\t\t20171012013638_EHI020C12","doi-asserted-by":"crossref","unstructured":"Al Suwaidi J, Reddan DN, Williams K et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation2002;106:974\u2013980.","DOI":"10.1161\/01.CIR.0000027560.41358.B3"},{"key":"key\n\t\t\t\t20171012013638_EHI020C13","doi-asserted-by":"crossref","unstructured":"Best PJ, Lennon R, Ting HH et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol2002;39:1113\u20131119.","DOI":"10.1016\/S0735-1097(02)01745-X"},{"key":"key\n\t\t\t\t20171012013638_EHI020C14","unstructured":"Rao V, Weisel RD, Buth KJ et al. Coronary artery bypass grafting in patients with non-dialysis-dependent renal insufficiency. Circulation1997;96(Suppl.):II-38\u201343; discussion II-44\u201345."},{"key":"key\n\t\t\t\t20171012013638_EHI020C15","doi-asserted-by":"crossref","unstructured":"Gibson CM, Pinto DS, Murphy SA et al. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol2003;42:1535\u20131543.","DOI":"10.1016\/j.jacc.2003.06.001"},{"key":"key\n\t\t\t\t20171012013638_EHI020C16","doi-asserted-by":"crossref","unstructured":"Wright RS, Reeder GS, Herzog CA et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med2002;137:563\u2013570.","DOI":"10.7326\/0003-4819-137-7-200210010-00007"},{"key":"key\n\t\t\t\t20171012013638_EHI020C17","doi-asserted-by":"crossref","unstructured":"Hillege HL, van Gilst WH, van Veldhuisen DJ et al. Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. Eur Heart J2003;24:412\u2013420.","DOI":"10.1016\/S0195-668X(02)00526-2"},{"key":"key\n\t\t\t\t20171012013638_EHI020C18","unstructured":"National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. USRDS 1998 Annual Data Report. Bethesda, MD, USA: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1998. http:\/\/www.usrds.org\/adr_1998.htm (20 January 2004)."},{"key":"key\n\t\t\t\t20171012013638_EHI020C19","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis2002;39(Suppl. 1):S1\u2013S266."},{"key":"key\n\t\t\t\t20171012013638_EHI020C20","doi-asserted-by":"crossref","unstructured":"McCullough PA, Philbin EF, Spertus JA et al. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol2002;39:60\u201369.","DOI":"10.1016\/S0735-1097(01)01700-4"},{"key":"key\n\t\t\t\t20171012013638_EHI020C21","doi-asserted-by":"crossref","unstructured":"Dzau VJ. Renal and circulatory mechanisms in congestive heart failure. Kidney Int1987;31:1402\u20131415.","DOI":"10.1038\/ki.1987.156"},{"key":"key\n\t\t\t\t20171012013638_EHI020C22","doi-asserted-by":"crossref","unstructured":"McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation2004;109:1004\u20131009.","DOI":"10.1161\/01.CIR.0000116764.53225.A9"},{"key":"key\n\t\t\t\t20171012013638_EHI020C23","doi-asserted-by":"crossref","unstructured":"Guyton AC. The surprising kidney-fluid mechanism for pressure control\u2013its infinite gain! Hypertension1990;16:725\u2013730.","DOI":"10.1161\/01.HYP.16.6.725"},{"key":"key\n\t\t\t\t20171012013638_EHI020C24","doi-asserted-by":"crossref","unstructured":"Dorhout Mees EJ. Cardiovascular Aspects of Dialysis Treatment: The Importance of Volume Control. Dordrecht\/Boston\/London: Kluwer Academic Publishers, 2000.","DOI":"10.1007\/978-94-017-0973-6"},{"key":"key\n\t\t\t\t20171012013638_EHI020C25","doi-asserted-by":"crossref","unstructured":"Bongartz LG, Cramer MJ, Braam B. The cardiorenal connection. Hypertension2004;43:e14.","DOI":"10.1161\/01.HYP.0000118521.06245.b8"},{"key":"key\n\t\t\t\t20171012013638_EHI020C26","doi-asserted-by":"crossref","unstructured":"Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med1974;290:697\u2013701.","DOI":"10.1056\/NEJM197403282901301"},{"key":"key\n\t\t\t\t20171012013638_EHI020C27","doi-asserted-by":"crossref","unstructured":"Clyne N, Lins LE, Pehrsson SK. Occurrence and significance of heart disease in uraemia. An autopsy study. Scand J Urol Nephrol1986;20:307\u2013311.","DOI":"10.3109\/00365598609024517"},{"key":"key\n\t\t\t\t20171012013638_EHI020C28","doi-asserted-by":"crossref","unstructured":"Oh J, Wunsch R, Turzer M et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation2002;106:100\u2013105.","DOI":"10.1161\/01.CIR.0000020222.63035.C0"},{"key":"key\n\t\t\t\t20171012013638_EHI020C29","doi-asserted-by":"crossref","unstructured":"Rambausek M, Ritz E, Mall G et al. Myocardial hypertrophy in rats with renal insufficiency. Kidney Int1985;28:775\u2013782.","DOI":"10.1038\/ki.1985.197"},{"key":"key\n\t\t\t\t20171012013638_EHI020C30","doi-asserted-by":"crossref","unstructured":"Stefanski A, Schmidt KG, Waldherr R, Ritz E. Early increase in blood pressure and diastolic left ventricular malfunction in patients with glomerulonephritis. Kidney Int1996;50:1321\u20131326.","DOI":"10.1038\/ki.1996.444"},{"key":"key\n\t\t\t\t20171012013638_EHI020C31","doi-asserted-by":"crossref","unstructured":"Tornig J, Gross ML, Simonaviciene A et al. Hypertrophy of intramyocardial arteriolar smooth muscle cells in experimental renal failure. J Am Soc Nephrol1999;10:77\u201383.","DOI":"10.1681\/ASN.V10177"},{"key":"key\n\t\t\t\t20171012013638_EHI020C32","doi-asserted-by":"crossref","unstructured":"Amann K, Breitbach M, Ritz E, Mall G. Myocyte\/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol1998;9:1018\u20131022.","DOI":"10.1681\/ASN.V961018"},{"key":"key\n\t\t\t\t20171012013638_EHI020C33","doi-asserted-by":"crossref","unstructured":"Vuurmans TJ, Boer P, Koomans HA. Effects of endothelin-1 and endothelin-1 receptor blockade on cardiac output, aortic pressure, and pulse wave velocity in humans. Hypertension2003;41:1253\u20131258.","DOI":"10.1161\/01.HYP.0000072982.70666.E8"},{"key":"key\n\t\t\t\t20171012013638_EHI020C34","doi-asserted-by":"crossref","unstructured":"Safar ME, London GM, Plante GE. Arterial stiffness and kidney function. Hypertension2004;43:163\u2013168.","DOI":"10.1161\/01.HYP.0000114571.75762.b0"},{"key":"key\n\t\t\t\t20171012013638_EHI020C35","doi-asserted-by":"crossref","unstructured":"Schwarz U, Buzello M, Ritz E et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant2000;15:218\u2013223.","DOI":"10.1093\/ndt\/15.2.218"},{"key":"key\n\t\t\t\t20171012013638_EHI020C36","doi-asserted-by":"crossref","unstructured":"Goodman WG, Goldin J, Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med2000;342:1478\u20131483.","DOI":"10.1056\/NEJM200005183422003"},{"key":"key\n\t\t\t\t20171012013638_EHI020C37","doi-asserted-by":"crossref","unstructured":"Raggi P, Boulay A, Chasan-Taber S et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol2002;39:695\u2013701.","DOI":"10.1016\/S0735-1097(01)01781-8"},{"key":"key\n\t\t\t\t20171012013638_EHI020C38","doi-asserted-by":"crossref","unstructured":"Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med1999;341:577\u2013585.","DOI":"10.1056\/NEJM199908193410806"},{"key":"key\n\t\t\t\t20171012013638_EHI020C39","doi-asserted-by":"crossref","unstructured":"Brewster UC, Perazella MA. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease. Am J Med2004;116:263\u2013272.","DOI":"10.1016\/j.amjmed.2003.09.034"},{"key":"key\n\t\t\t\t20171012013638_EHI020C40","doi-asserted-by":"crossref","unstructured":"Braam B, Koomans HA. Renal responses to antagonism of the renin-angiotensin system. Curr Opin Nephrol Hypertens1996;5:89\u201396.","DOI":"10.1097\/00041552-199601000-00015"},{"key":"key\n\t\t\t\t20171012013638_EHI020C41","doi-asserted-by":"crossref","unstructured":"Warren DJ, Ferris TF. Renin secretion in renal hypertension. Lancet1970;1:159\u2013162.","DOI":"10.1016\/S0140-6736(70)90404-6"},{"key":"key\n\t\t\t\t20171012013638_EHI020C42","doi-asserted-by":"crossref","unstructured":"Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res1994;74:1141\u20131148.","DOI":"10.1161\/01.RES.74.6.1141"},{"key":"key\n\t\t\t\t20171012013638_EHI020C43","doi-asserted-by":"crossref","unstructured":"Ushio-Fukai M, Zafari AM, Fukui T et al. p22phox is a critical component of the superoxide-generating NADH\/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem1996;271:23317\u201323321.","DOI":"10.1074\/jbc.271.38.23317"},{"key":"key\n\t\t\t\t20171012013638_EHI020C44","doi-asserted-by":"crossref","unstructured":"Chabrashvili T, Kitiyakara C, Blau J et al. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Regul Integr Comp Physiol2003;285:R117\u2013R124.","DOI":"10.1152\/ajpregu.00476.2002"},{"key":"key\n\t\t\t\t20171012013638_EHI020C45","doi-asserted-by":"crossref","unstructured":"Nakagami H, Takemoto M, Liao JK. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy. J Mol Cell Cardiol2003;35:851\u2013859.","DOI":"10.1016\/S0022-2828(03)00145-7"},{"key":"key\n\t\t\t\t20171012013638_EHI020C46","doi-asserted-by":"crossref","unstructured":"Heymes C, Bendall JK, Ratajczak P et al. Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol2003;41:2164\u20132171.","DOI":"10.1016\/S0735-1097(03)00471-6"},{"key":"key\n\t\t\t\t20171012013638_EHI020C47","doi-asserted-by":"crossref","unstructured":"Tojo A, Onozato ML, Kobayashi N et al. Angiotensin II and oxidative stress in Dahl Salt-sensitive rat with heart failure. Hypertension2002;40:834\u2013839.","DOI":"10.1161\/01.HYP.0000039506.43589.D5"},{"key":"key\n\t\t\t\t20171012013638_EHI020C48","doi-asserted-by":"crossref","unstructured":"Hornig B, Landmesser U, Kohler C et al. Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase. Circulation2001;103:799\u2013805.","DOI":"10.1161\/01.CIR.103.6.799"},{"key":"key\n\t\t\t\t20171012013638_EHI020C49","doi-asserted-by":"crossref","unstructured":"Ruiz-Ortega M, Lorenzo O, Egido J. Angiotensin III increases MCP-1 and activates NF-kappaB and AP-1 in cultured mesangial and mononuclear cells. Kidney Int2000;57:2285\u20132298.","DOI":"10.1046\/j.1523-1755.2000.00089.x"},{"key":"key\n\t\t\t\t20171012013638_EHI020C50","doi-asserted-by":"crossref","unstructured":"Pueyo ME, Gonzalez W, Nicoletti A et al. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol2000;20:645\u2013651.","DOI":"10.1161\/01.ATV.20.3.645"},{"key":"key\n\t\t\t\t20171012013638_EHI020C51","doi-asserted-by":"crossref","unstructured":"Reid IA. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol1992;262:E763\u2013E778.","DOI":"10.1152\/ajpendo.1992.262.6.E763"},{"key":"key\n\t\t\t\t20171012013638_EHI020C52","doi-asserted-by":"crossref","unstructured":"Converse RL Jr, Jacobsen TN, Toto RD et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med1992;327:1912\u20131918.","DOI":"10.1056\/NEJM199212313272704"},{"key":"key\n\t\t\t\t20171012013638_EHI020C53","doi-asserted-by":"crossref","unstructured":"Ligtenberg G, Blankestijn PJ, Oey PL et al. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med1999;340:1321\u20131328.","DOI":"10.1056\/NEJM199904293401704"},{"key":"key\n\t\t\t\t20171012013638_EHI020C54","doi-asserted-by":"crossref","unstructured":"Klein IH, Ligtenberg G, Oey PL et al. Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure. J Am Soc Nephrol2003;14:425\u2013430.","DOI":"10.1097\/01.ASN.0000045049.72965.B7"},{"key":"key\n\t\t\t\t20171012013638_EHI020C55","doi-asserted-by":"crossref","unstructured":"Zhang W, Huang BS, Leenen FH. Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction. Am J Physiol1999;276:H1608\u2013H1615.","DOI":"10.1152\/ajpheart.1999.276.5.H1608"},{"key":"key\n\t\t\t\t20171012013638_EHI020C56","doi-asserted-by":"crossref","unstructured":"Braam B. Renal endothelial and macula densa NOS: integrated response to changes in extracellular fluid volume. Am J Physiol1999;276(Pt 2):R1551\u2013R1561.","DOI":"10.1152\/ajpregu.1999.276.6.R1551"},{"key":"key\n\t\t\t\t20171012013638_EHI020C57","doi-asserted-by":"crossref","unstructured":"Zou AP, Li N, Cowley AW Jr. Production and actions of superoxide in the renal medulla. Hypertension2001;37:547\u2013553.","DOI":"10.1161\/01.HYP.37.2.547"},{"key":"key\n\t\t\t\t20171012013638_EHI020C58","doi-asserted-by":"crossref","unstructured":"Welch WJ, Wilcox CS. AT1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR. Kidney Int2001;59:1257\u20131263.","DOI":"10.1046\/j.1523-1755.2001.0590041257.x"},{"key":"key\n\t\t\t\t20171012013638_EHI020C59","doi-asserted-by":"crossref","unstructured":"Ren Y, Carretero OA, Garvin JL. Mechanism by which superoxide potentiates tubuloglomerular feedback. Hypertension2002; 39:624\u2013628.","DOI":"10.1161\/hy0202.103299"},{"key":"key\n\t\t\t\t20171012013638_EHI020C60","doi-asserted-by":"crossref","unstructured":"Ortiz PA, Garvin JL. Interaction of O(2)(-) and NO in the thick ascending limb. Hypertension2002;39:591\u2013596.","DOI":"10.1161\/hy0202.103287"},{"key":"key\n\t\t\t\t20171012013638_EHI020C61","doi-asserted-by":"crossref","unstructured":"Handelman GJ, Walter MF, Adhikarla R et al. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int2001;59:1960\u20131966.","DOI":"10.1046\/j.1523-1755.2001.0590051960.x"},{"key":"key\n\t\t\t\t20171012013638_EHI020C62","doi-asserted-by":"crossref","unstructured":"Maggi E, Bellazzi R, Gazo A et al. Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis. Kidney Int1994;46:869\u2013876.","DOI":"10.1038\/ki.1994.344"},{"key":"key\n\t\t\t\t20171012013638_EHI020C63","doi-asserted-by":"crossref","unstructured":"Ha TK, Sattar N, Talwar D et al. Abnormal antioxidant vitamin and carotenoid status in chronic renal failure. QJMed1996;89:765\u2013769.","DOI":"10.1093\/qjmed\/89.10.765"},{"key":"key\n\t\t\t\t20171012013638_EHI020C64","doi-asserted-by":"crossref","unstructured":"Vallance P, Leone A, Calver A et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet1992;339:572\u2013575.","DOI":"10.1016\/0140-6736(92)90865-Z"},{"key":"key\n\t\t\t\t20171012013638_EHI020C65","unstructured":"Hill MF, Singal PK. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol1996;148:291\u2013300."},{"key":"key\n\t\t\t\t20171012013638_EHI020C66","doi-asserted-by":"crossref","unstructured":"Khaper N, Singal PK. Effects of afterload-reducing drugs on pathogenesis of antioxidant changes and congestive heart failure in rats. J Am Coll Cardiol1997;29:856\u2013861.","DOI":"10.1016\/S0735-1097(96)00574-8"},{"key":"key\n\t\t\t\t20171012013638_EHI020C67","doi-asserted-by":"crossref","unstructured":"Kielstein JT, Bode-Boger SM, Klein G et al. Endogenous nitric oxide synthase inhibitors and renal perfusion in patients with heart failure. Eur J Clin Invest2003;33:370\u2013375.","DOI":"10.1046\/j.1365-2362.2003.01149.x"},{"key":"key\n\t\t\t\t20171012013638_EHI020C68","doi-asserted-by":"crossref","unstructured":"Lin HH, Chen CH, Hsieh WK et al. Hydrogen peroxide increases the activity of rat sympathetic preganglionic neurons in vivo and in vitro. Neuroscience2003;121:641\u2013647.","DOI":"10.1016\/S0306-4522(03)00517-7"},{"key":"key\n\t\t\t\t20171012013638_EHI020C69","doi-asserted-by":"crossref","unstructured":"Shokoji T, Nishiyama A, Fujisawa Y et al. Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats. Hypertension2003;41:266\u2013273.","DOI":"10.1161\/01.HYP.0000049621.85474.CF"},{"key":"key\n\t\t\t\t20171012013638_EHI020C70","doi-asserted-by":"crossref","unstructured":"Miyata T, Sugiyama S, Saito A, Kurokawa K. Reactive carbonyl compounds related uremic toxicity (\u2018carbonyl stress\u2019). Kidney Int Suppl2001;78:S25\u2013S31.","DOI":"10.1046\/j.1523-1755.2001.59780025.x"},{"key":"key\n\t\t\t\t20171012013638_EHI020C71","doi-asserted-by":"crossref","unstructured":"Witko-Sarsat V, Friedlander M, Capeillere-Blandin C et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int1996;49:1304\u20131313.","DOI":"10.1038\/ki.1996.186"},{"key":"key\n\t\t\t\t20171012013638_EHI020C72","doi-asserted-by":"crossref","unstructured":"Miyata T, Maeda K, Kurokawa K, van Ypersele de Strihou C. Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure. Nephrol Dial Transplant1997;12:255\u2013258.","DOI":"10.1093\/ndt\/12.2.255"},{"key":"key\n\t\t\t\t20171012013638_EHI020C73","doi-asserted-by":"crossref","unstructured":"Witko-Sarsat V, Friedlander M, Nguyen Khoa T et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol1998;161:2524\u20132532.","DOI":"10.4049\/jimmunol.161.5.2524"},{"key":"key\n\t\t\t\t20171012013638_EHI020C74","doi-asserted-by":"crossref","unstructured":"Nguyen-Khoa T, Massy ZA, Witko-Sarsat V et al. Oxidized low-density lipoprotein induces macrophage respiratory burst via its protein moiety: A novel pathway in atherogenesis? Biochem Biophys Res Commun1999;263:804\u2013809.","DOI":"10.1006\/bbrc.1999.1438"},{"key":"key\n\t\t\t\t20171012013638_EHI020C75","doi-asserted-by":"crossref","unstructured":"Herbst U, Toborek M, Kaiser S et al. 4-Hydroxynonenal induces dysfunction and apoptosis of cultured endothelial cells. J Cell Physiol1999;181:295\u2013303.","DOI":"10.1002\/(SICI)1097-4652(199911)181:2<295::AID-JCP11>3.0.CO;2-I"},{"key":"key\n\t\t\t\t20171012013638_EHI020C76","doi-asserted-by":"crossref","unstructured":"Katoh M, Egashira K, Usui M et al. Cardiac angiotensin II receptors are upregulated by long-term inhibition of nitric oxide synthesis in rats. Circ Res1998;83:743\u2013751.","DOI":"10.1161\/01.RES.83.7.743"},{"key":"key\n\t\t\t\t20171012013638_EHI020C77","doi-asserted-by":"crossref","unstructured":"Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int2002;62:1524\u20131538.","DOI":"10.1046\/j.1523-1755.2002.00600.x"},{"key":"key\n\t\t\t\t20171012013638_EHI020C78","doi-asserted-by":"crossref","unstructured":"Boaz M, Smetana S, Weinstein T et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet2000;356:1213\u20131218.","DOI":"10.1016\/S0140-6736(00)02783-5"},{"key":"key\n\t\t\t\t20171012013638_EHI020C79","doi-asserted-by":"crossref","unstructured":"Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int2001;59:407\u2013414.","DOI":"10.1046\/j.1523-1755.2001.059002407.x"},{"key":"key\n\t\t\t\t20171012013638_EHI020C80","doi-asserted-by":"crossref","unstructured":"Zebrack JS, Anderson JL, Beddhu S et al. Do associations with C-reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency? J Am Coll Cardiol2003;42:57\u201363.","DOI":"10.1016\/S0735-1097(03)00564-3"},{"key":"key\n\t\t\t\t20171012013638_EHI020C81","doi-asserted-by":"crossref","unstructured":"Zoccali C, Benedetto FA, Mallamaci F et al. Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients. J Hypertens2000;18:1207\u20131213.","DOI":"10.1097\/00004872-200018090-00006"},{"key":"key\n\t\t\t\t20171012013638_EHI020C82","doi-asserted-by":"crossref","unstructured":"Irish A. Cardiovascular disease, fibrinogen and the acute phase response: associations with lipids and blood pressure in patients with chronic renal disease. Atherosclerosis1998;137:133\u2013139.","DOI":"10.1016\/S0021-9150(97)00273-6"},{"key":"key\n\t\t\t\t20171012013638_EHI020C83","doi-asserted-by":"crossref","unstructured":"Bologa RM, Levine DM, Parker TS et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis1998;32:107\u2013114.","DOI":"10.1053\/ajkd.1998.v32.pm9669431"},{"key":"key\n\t\t\t\t20171012013638_EHI020C84","doi-asserted-by":"crossref","unstructured":"Levine B, Kalman J, Mayer L et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med1990;323:236\u2013241.","DOI":"10.1056\/NEJM199007263230405"},{"key":"key\n\t\t\t\t20171012013638_EHI020C85","doi-asserted-by":"crossref","unstructured":"Torre-Amione G, Kapadia S, Benedict C et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol1996;27:1201\u20131206.","DOI":"10.1016\/0735-1097(95)00589-7"},{"key":"key\n\t\t\t\t20171012013638_EHI020C86","doi-asserted-by":"crossref","unstructured":"Woldbaek PR, Tonnessen T, Henriksen UL et al. Increased cardiac IL-18 mRNA, pro-IL-18 and plasma IL-18 after myocardial infarction in the mouse; a potential role in cardiac dysfunction. Cardiovasc Res2003;59:122\u2013131.","DOI":"10.1016\/S0008-6363(03)00339-0"},{"key":"key\n\t\t\t\t20171012013638_EHI020C87","doi-asserted-by":"crossref","unstructured":"Ward RA, McLeish KR. Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency. J Am Soc Nephrol1995;5:1697\u20131702.","DOI":"10.1681\/ASN.V591697"},{"key":"key\n\t\t\t\t20171012013638_EHI020C88","doi-asserted-by":"crossref","unstructured":"Wassmann S, Stumpf M, Strehlow K et al. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res2004;94:534\u2013541.","DOI":"10.1161\/01.RES.0000115557.25127.8D"},{"key":"key\n\t\t\t\t20171012013638_EHI020C89","doi-asserted-by":"crossref","unstructured":"Sanchez-Lozada LG, Tapia E, Johnson RJ et al. Glomerular hemodynamic changes associated with arteriolar lesions and tubulointerstitial inflammation. Kidney Int Suppl2003;64(Suppl. 86):S9\u2013S14.","DOI":"10.1046\/j.1523-1755.64.s86.3.x"},{"key":"key\n\t\t\t\t20171012013638_EHI020C90","doi-asserted-by":"crossref","unstructured":"Deten A, Volz HC, Briest W, Zimmer HG. Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc Res2002;55:329\u2013340.","DOI":"10.1016\/S0008-6363(02)00413-3"},{"key":"key\n\t\t\t\t20171012013638_EHI020C91","doi-asserted-by":"crossref","unstructured":"Ono K, Matsumori A, Shioi T et al. Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation1998;98:149\u2013156.","DOI":"10.1161\/01.CIR.98.2.149"},{"key":"key\n\t\t\t\t20171012013638_EHI020C92","doi-asserted-by":"crossref","unstructured":"Niijima A, Hori T, Aou S, Oomura Y. The effects of interleukin-1 beta on the activity of adrenal, splenic and renal sympathetic nerves in the rat. J Auton Nerv Syst1991;36:183\u2013192.","DOI":"10.1016\/0165-1838(91)90042-2"},{"key":"key\n\t\t\t\t20171012013638_EHI020C93","doi-asserted-by":"crossref","unstructured":"Jackson G, Gibbs CR, Davies MK, Lip GY. ABC of heart failure. Pathophysiology. Br Med J2000;320:167\u2013170.","DOI":"10.1136\/bmj.320.7228.167"},{"key":"key\n\t\t\t\t20171012013638_EHI020C94","doi-asserted-by":"crossref","unstructured":"Luo M, Hess MC, Fink GD et al. Differential alterations in sympathetic neurotransmission in mesenteric arteries and veins in DOCA-salt hypertensive rats. Auton Neurosci2003;104:47\u201357.","DOI":"10.1016\/S1566-0702(02)00287-4"},{"key":"key\n\t\t\t\t20171012013638_EHI020C95","doi-asserted-by":"crossref","unstructured":"Amin JK, Xiao L, Pimental DR et al. Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J Mol Cell Cardiol2001;33:131\u2013139.","DOI":"10.1006\/jmcc.2000.1285"},{"key":"key\n\t\t\t\t20171012013638_EHI020C96","doi-asserted-by":"crossref","unstructured":"Leineweber K, Heinroth-Hoffmann I, Ponicke K et al. Cardiac beta-adrenoceptor desensitization due to increased beta-adrenoceptor kinase activity in chronic uremia. J Am Soc Nephrol2002;13:117\u2013124.","DOI":"10.1681\/ASN.V131117"},{"key":"key\n\t\t\t\t20171012013638_EHI020C97","doi-asserted-by":"crossref","unstructured":"Bristow MR, Ginsburg R, Minobe W et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med1982;307:205\u2013211.","DOI":"10.1056\/NEJM198207223070401"},{"key":"key\n\t\t\t\t20171012013638_EHI020C98","doi-asserted-by":"crossref","unstructured":"Maurice JP, Shah AS, Kypson AP et al. Molecular beta-adrenergic signaling abnormalities in failing rabbit hearts after infarction. Am J Physiol1999;276:H1853\u2013H1860.","DOI":"10.1152\/ajpheart.1999.276.6.H1853"},{"key":"key\n\t\t\t\t20171012013638_EHI020C99","doi-asserted-by":"crossref","unstructured":"Ruffolo RR Jr, Feuerstein GZ. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure. Cardiovasc Drugs Ther1997;11(Suppl. 1):247\u2013256.","DOI":"10.1023\/A:1007735729121"},{"key":"key\n\t\t\t\t20171012013638_EHI020C100","doi-asserted-by":"crossref","unstructured":"Wikstrand J, Berglund G, Hedblad B, Hulthe J. Antiatherosclerotic effects of beta-blockers. Am J Cardiol2003;91:25H\u201329H.","DOI":"10.1016\/S0002-9149(03)00431-4"},{"key":"key\n\t\t\t\t20171012013638_EHI020C101","doi-asserted-by":"crossref","unstructured":"Erami C, Zhang H, Ho JG et al. Alpha(1)-adrenoceptor stimulation directly induces growth of vascular wall in vivo. Am J Physiol Heart Circ Physiol2002;283:H1577\u2013H1587.","DOI":"10.1152\/ajpheart.00218.2002"},{"key":"key\n\t\t\t\t20171012013638_EHI020C102","doi-asserted-by":"crossref","unstructured":"Bleeke T, Zhang H, Madamanchi N et al. Catecholamine-induced vascular wall growth is dependent on generation of reactive oxygen species. Circ Res2004;94:37\u201345.","DOI":"10.1161\/01.RES.0000109412.80157.7D"},{"key":"key\n\t\t\t\t20171012013638_EHI020C103","doi-asserted-by":"crossref","unstructured":"Bianchi P, Seguelas MH, Parini A, Cambon C. Activation of pro-apoptotic cascade by dopamine in renal epithelial cells is fully dependent on hydrogen peroxide generation by monoamine oxidases. J Am Soc Nephrol2003;14:855\u2013862.","DOI":"10.1097\/01.ASN.0000058909.00567.5C"},{"key":"key\n\t\t\t\t20171012013638_EHI020C104","doi-asserted-by":"crossref","unstructured":"Liao J, Keiser JA, Scales WE et al. Role of epinephrine in TNF and IL-6 production from isolated perfused rat liver. Am J Physiol1995;268:R896\u2013R901.","DOI":"10.1152\/ajpregu.1995.268.4.R896"},{"key":"key\n\t\t\t\t20171012013638_EHI020C105","doi-asserted-by":"crossref","unstructured":"Oddis CV, Simmons RL, Hattler BG, Finkel MS. cAMP enhances inducible nitric oxide synthase mRNA stability in cardiac myocytes. Am J Physiol1995;269(Pt 2):H2044\u2013H2050.","DOI":"10.1152\/ajpheart.1995.269.6.H2044"},{"key":"key\n\t\t\t\t20171012013638_EHI020C106","doi-asserted-by":"crossref","unstructured":"Prabhu SD, Chandrasekar B, Murray DR, Freeman GL. beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation2000;101:2103\u20132109.","DOI":"10.1161\/01.CIR.101.17.2103"},{"key":"key\n\t\t\t\t20171012013638_EHI020C107","doi-asserted-by":"crossref","unstructured":"Li L, Lee EW, Ji H, Zukowska Z. Neuropeptide Y-induced acceleration of postangioplasty occlusion of rat carotid artery. Arterioscler Thromb Vasc Biol2003;23:1204\u20131210.","DOI":"10.1161\/01.ATV.0000071349.30914.25"},{"key":"key\n\t\t\t\t20171012013638_EHI020C108","doi-asserted-by":"crossref","unstructured":"Schwarz H, Villiger PM, von Kempis J, Lotz M. Neuropeptide Y is an inducible gene in the human immune system. J Neuroimmunol1994;51:53\u201361.","DOI":"10.1016\/0165-5728(94)90128-7"},{"key":"key\n\t\t\t\t20171012013638_EHI020C109","doi-asserted-by":"crossref","unstructured":"Zukowska-Grojec Z. Neuropeptide Y. A novel sympathetic stress hormone and more. Ann N Y Acad Sci1995;771:219\u2013233.","DOI":"10.1111\/j.1749-6632.1995.tb44683.x"},{"key":"key\n\t\t\t\t20171012013638_EHI020C110","doi-asserted-by":"crossref","unstructured":"Morris MJ, Cox HS, Lambert GW et al. Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans. Hypertension1997;29:137\u2013143.","DOI":"10.1161\/01.HYP.29.1.137"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/26\/1\/11\/5941686\/ehi020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T16:29:44Z","timestamp":1682872184000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/eurheartj\/article\/26\/1\/11\/494643\/The-severe-cardiorenal-syndrome-Guyton-revisited"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,30]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,11,30]]},"published-print":{"date-parts":[[2005,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehi020","relation":{},"ISSN":["1522-9645","0195-668X"],"issn-type":[{"value":"1522-9645","type":"electronic"},{"value":"0195-668X","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,1]]},"published":{"date-parts":[[2004,11,30]]}}}